Certified by Founder Lodge
Evozyne
United States - Chicago, IL
START UP
1 Disclosed Funding Rounds $81,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. B
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 28 ,2023 | Series B | $81,000,000 |
Valor Equity Partners
OrbiMed
Fidelity Investments
Paragon Biosciences
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Voio | $8,600,000 | (Nov 21, 2025)
Stuut | $29,500,000 | (Nov 21, 2025)
Made Card | $8,000,000 | (Nov 21, 2025)
Revenium | $13,500,000 | (Nov 21, 2025)
EQORE | $1,700,000 | (Nov 21, 2025)
